DMG

Clinical trials for DMG explained in plain language.

Never miss a new study

Get alerted when new DMG trials appear

Sign up with your email to follow new studies for DMG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Engineered immune cells target deadly brain tumors in children

Disease control Not yet recruiting

This study tests a new treatment called BCB-276 for children and young adults with diffuse intrinsic pontine glioma (DIPG), a rare and aggressive brain tumor. BCB-276 is made from a patient's own immune cells, which are modified in a lab to recognize and attack the cancer. The tr…

Matched conditions: DMG

Phase: PHASE2 • Sponsor: BrainChild Bio, Inc • Aim: Disease control

Last updated Jul 03, 2026 20:17 UTC

DMG

Get alerted when new DMG trials appear

Engineered immune cells target deadly brain tumors in children